Forte Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $38 | $0 |
Gross Profit | -15 | -13 | 19 | -10 |
EBITDA | -11,564 | -16,124 | -7,341 | -8,619 |
EBIT | -11,579 | -16,137 | -7,351 | -8,629 |
Net Income | -11,249 | -15,656 | -7,155 | -8,392 |
Net Change In Cash | 0 | 0 | 38 | 0 |
Free Cash Flow | -10,061 | -10,416 | -10,040 | -8,133 |
Cash | 106,144 | 45,856 | 22,244 | 16,363 |
Basic Shares | 11,744 | 11,398 | 6,393 | 1,847 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -39 | -9 | -36 | |
EBITDA | -35,439 | -32,476 | -13,896 | -21,450 |
EBIT | -35,478 | -32,485 | -13,896 | -21,486 |
Net Income | -35,478 | -31,476 | -13,862 | -21,708 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -30,782 | -28,794 | -8,185 | -16,677 |
Cash | 22,244 | 11,961 | 41,100 | 42,044 |
Basic Shares | 2,915 | 1,262 | 695 | 558 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.96 |
2025-03-31 | -$1.37 |
2024-12-31 | -$1.17 |
2024-09-30 | -$4.54 |
